Publication | Open Access

Recombinant human lactoferrin carrying humanized glycosylation exhibits antileukemia selective cytotoxicity, microfilament disruption, cell cycle arrest, and apoptosis activities

MedicineApoptosisImmunologyGlycobiologyCell DeathRecombinant Human LactoferrinMicrofilament DisruptionAnti-cancer AgentGlycosylation ExhibitsPharmacologyCell BiologyGlycosylation